Daniela Gundisch - Publications

Affiliations: 
University of Bonn, Bonn, Nordrhein-Westfalen, Germany 
Area:
Organic Chemistry

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Sun D, Gündisch D. Privileged Scaffolds in Natural Products and Drug Discovery. Current Topics in Medicinal Chemistry. PMID 26456462  0.32
2015 Tsutsumi LS, Gündisch D, Sun D. Carbazole Scaffold in Medicinal Chemistry and Natural Products: A Review from 2010-2015. Current Topics in Medicinal Chemistry. PMID 26369811  0.32
2013 Eibl C, Tomassoli I, Munoz L, Stokes C, Papke RL, Gündisch D. The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituents. Bioorganic & Medicinal Chemistry. 21: 7283-308. PMID 24156938 DOI: 10.1016/j.bmc.2013.09.059  0.32
2013 Eibl C, Munoz L, Tomassoli I, Stokes C, Papke RL, Gündisch D. The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifs. Bioorganic & Medicinal Chemistry. 21: 7309-29. PMID 24145137 DOI: 10.1016/j.bmc.2013.09.060  0.32
2012 Pérez EG, Cassels BK, Eibl C, Gündisch D. Synthesis and evaluation of N(1)-alkylindole-3-ylalkylammonium compounds as nicotinic acetylcholine receptor ligands. Bioorganic & Medicinal Chemistry. 20: 3719-27. PMID 22609074 DOI: 10.1016/j.bmc.2012.04.050  0.32
2011 Gündisch D, Eibl C. Nicotinic acetylcholine receptor ligands, a patent review (2006-2011). Expert Opinion On Therapeutic Patents. 21: 1867-96. PMID 22098319 DOI: 10.1517/13543776.2011.637919  0.32
2011 Mineur YS, Abizaid A, Rao Y, Salas R, DiLeone RJ, Gündisch D, Diano S, De Biasi M, Horvath TL, Gao XB, Picciotto MR. Nicotine decreases food intake through activation of POMC neurons. Science (New York, N.Y.). 332: 1330-2. PMID 21659607 DOI: 10.1126/science.1201889  0.32
2009 Mineur YS, Eibl C, Young G, Kochevar C, Papke RL, Gündisch D, Picciotto MR. Cytisine-based nicotinic partial agonists as novel antidepressant compounds. The Journal of Pharmacology and Experimental Therapeutics. 329: 377-86. PMID 19164465 DOI: 10.1124/jpet.108.149609  0.32
2008 Wüllner U, Gündisch D, Herzog H, Minnerop M, Joe A, Warnecke M, Jessen F, Schütz C, Reinhardt M, Eschner W, Klockgether T, Schmaljohann J. Smoking upregulates alpha4beta2* nicotinic acetylcholine receptors in the human brain. Neuroscience Letters. 430: 34-7. PMID 17997038 DOI: 10.1016/j.neulet.2007.10.011  0.32
2006 Schmaljohann J, Gündisch D, Minnerop M, Bucerius J, Joe A, Reinhardt M, Guhlke S, Biersack HJ, Wüllner U. In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease. Nuclear Medicine and Biology. 33: 305-9. PMID 16631078 DOI: 10.1016/j.nucmedbio.2005.12.012  0.32
2005 Schmaljohann J, Gündisch D, Minnerop M, Joe A, Bucerius J, Dittmar C, Jessen F, Guhlke S, Wüllner U. A simple and fast method for the preparation of n.c.a. 2-[18F]F-A85380 for human use. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 63: 433-5. PMID 16024252 DOI: 10.1016/j.apradiso.2005.05.040  0.32
2005 Lain E, Penke B, Delacourte A, Gündisch D, Schröder H, Witter B. Effects of Abeta1-42 fibrils and of the tetrapeptide Pr-IIGL on the phosphorylation state of the tau-protein and on the alpha7 nicotinic acetylcholine receptor in vitro. The European Journal of Neuroscience. 21: 879-88. PMID 15787694 DOI: 10.1111/j.1460-9568.2005.03909.x  0.32
2005 Fitch RW, Kaneko Y, Klaperski P, Daly JW, Seitz G, Gündisch D. Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors. Bioorganic & Medicinal Chemistry Letters. 15: 1221-4. PMID 15686946 DOI: 10.1016/j.bmcl.2004.11.073  0.32
2005 Gündisch D, Koren AO, Horti AG, Pavlova OA, Kimes AS, Mukhin AG, London ED. In vitro characterization of 6-[18F]fluoro-A-85380, a high-affinity ligand for alpha4beta2* nicotinic acetylcholine receptors. Synapse (New York, N.Y.). 55: 89-97. PMID 15529332 DOI: 10.1002/syn.20096  0.32
2002 Gohlke H, Gündisch D, Schwarz S, Seitz G, Tilotta MC, Wegge T. Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165. Journal of Medicinal Chemistry. 45: 1064-72. PMID 11855986 DOI: 10.1021/jm010936y  0.32
2000 Horti AG, Chefer SI, Mukhin AG, Koren AO, Gündisch D, Links JM, Kurian V, Dannals RF, London ED. 6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. Life Sciences. 67: 463-9. PMID 11003056 DOI: 10.1016/S0024-3205(00)00635-4  0.32
2000 Harms A, Gündisch D, Müller CE, Kovar KA. Development of a 5-hydroxytryptamine(2A) receptor binding assay for high throughput screening using 96-well microfilter plates. Journal of Biomolecular Screening. 5: 269-78. PMID 10992048  0.32
2000 Mukhin AG, Gündisch D, Horti AG, Koren AO, Tamagnan G, Kimes AS, Chambers J, Vaupel DB, King SL, Picciotto MR, Innis RB, London ED. 5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors. Molecular Pharmacology. 57: 642-9. PMID 10692507 DOI: 10.1124/MOL.57.3.642  0.32
2000 Koren AO, Horti AG, Mukhin AG, Gündisch D, Dannals RF, London ED. Synthesis and initial in vitro characterization of 6-[18F]fluoro-3-(2(S)-azetidinylmethoxy)puridine, a high-affinity radioligand for central nicotinic acetylcholine receptors Journal of Labelled Compounds and Radiopharmaceuticals. 43: 413-423. DOI: 10.1002/(SICI)1099-1344(200004)43:5<413::AID-JLCR326>3.0.CO;2-1  0.32
1999 Chefer SI, Horti AG, Koren AO, Gündisch D, Links JM, Kurian V, Dannals RF, Mukhin AG, London ED. 2-[18F]F-A-85380: a PET radioligand for alpha4beta2 nicotinic acetylcholine receptors. Neuroreport. 10: 2715-21. PMID 10511429 DOI: 10.1097/00001756-199909090-00005  0.32
1999 Patt M, Gundisch D, Wullner U, Blocher A, Kovar KA, Machulla HJ. N-[11C]methyl-3,4-methylenedioxyamphetamine (Ecstasy) and 2-methyl-N- [11C]methyl-4,5-methylenedioxyamphetamine: Synthesis and biodistribution studies Journal of Radioanalytical and Nuclear Chemistry. 240: 535-540. DOI: 10.1007/BF02349410  0.32
1999 Koren AO, Horti AG, Mukhin AG, Gundisch D, Dannals RF, London ED. Synthesis and in vitro charactertzation of 6-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine, a high-affinity radioligand for central nicotinic acetylcholine receptors Journal of Labelled Compounds and Radiopharmaceuticals. 42: S409-S410.  0.32
1997 Solbach M, Gundisch D, Blocher A, Kovar KA, Machulla HJ. Preparation of N-[11C]methyl-2,5-dimethoxy-4-methylamphetamine Journal of Radioanalytical and Nuclear Chemistry. 220: 109-111. DOI: 10.1007/BF02035359  0.32
1997 Solbach M, Gundisch D, Blocher A, Kovar KA, Machulla HJ. Preparation of N-[11C]methyl-2,5-dimethoxy-4-bromo-amphetamine Journal of Radioanalytical and Nuclear Chemistry. 221: 211-212. DOI: 10.1007/BF02035269  0.32
1997 Solbach M, Gundisch D, Wullner U, Stahlschmidt A, Kovar KA, Machulla HJ. N-[11C]methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB): Synthesis, quality control and biodistribution Journal of Radioanalytical and Nuclear Chemistry. 224: 109-112. DOI: 10.1007/BF02034621  0.32
1994 Gundisch D, Kovar KA. On the mechanism of the reaction of o-benzenesulfonamide-p-benzoquinone with ammonia and amines Archiv Der Pharmazie. 327: 55-59.  0.32
Show low-probability matches.